Clinical Cancer esearch cer Therapy : Clinical uential Cytarabine and α-Particle Immunotherapy Bismuth-213 – Lintuzumab ( HuM 195 ) for R te Myeloid Leukemia
暂无分享,去创建一个
D. Scheinberg | M. McDevitt | C. Divgi | G. Sgouros | M. Heaney | N. Pandit-Taskar | J. Jurcic | A. Morgenstern | D. Mulford | S. Chanel | M. Larson | Todd Kathe Steve | L. Rosenblat | rine S. Panageas